01重点学术场次Priority Sessions1 场
本专题的重点场次包含 Hot Line、LBCS、New ESC Guidelines、Ask the Trialists、Guidelines in Practice、Great Debates 等。
肿瘤心脏病学1 场
LBCS
晚期临床科学:肿瘤心脏病学
Late-Breaking Clinical Science: cardio-oncology
前列腺癌患者心血管与生活方式危险因素随机干预研究
A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
HER2 靶向治疗相关心脏功能障碍恢复后停用药物治疗安全性的开放标签随机对照试验
An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.
癌症患者动脉血栓的发生率与预测因素:前瞻性 COMPASS 癌症相关动脉血栓(COMPASS-ARTeCAT)研究
Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study
心力衰竭与血液系统恶性肿瘤新发风险:全国人群队列研究
Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study
03本领域中国研究China Abstracts44 篇
| 研究标题 | 第一作者 | 所在机构 |
|---|---|---|
| 心脏肿瘤学 · 14 篇 | ||
IgG N-糖基化作为免疫检查点抑制剂相关心肌炎的新型生物标志物:比较糖组学研究 IgG N-glycosylation as a novel biomarker for immune checkpoint inhibitor-associated myocarditis: a comparative glycomic study | Jingyi Li | 北京协和医院 |
免疫检查点抑制剂在亚洲人群中的真实世界心血管毒性:台湾全国注册研究的启示 Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry | Kuan Ting Chen | 马偕纪念医院 |
中性粒细胞经NET/NETosis轴参与αPD1诱导的潜在心肌损伤:ICI相关心肌炎的病理机制、诊断标志物与治疗靶点探索 Neutrophils contribute to αPD1-induced latent myocardial injury via NET/NETosis axis: exploration of potential patho-mechanism, diagnostic biomarkers and therapeutic targets in ICIs-associated myocard | Yifan Chen | 厦门心脏中心 |
FOXA1+CD3+T淋巴细胞经DLL1/Notch1/GSDMD信号通路加重免疫检查点抑制剂相关心肌炎的心肌损伤 FOXA1+CD3+T lymphocytes exacerbate myocardial injury in immune checkpoint inhibitor associated myocarditis via the DLL1/Notch1/GSDMD signaling pathway | Xiaoling Liu | 山东大学齐鲁医院 |
循环DKK1升高与非小细胞肺癌早期肺血管重构相关 Elevated circulating DKK1 is associated with pulmonary vascular remodeling in early-stage non-small cell lung cancer | Mengmeng Li | 山东大学齐鲁医院 |
洛拉替尼与其他ALK抑制剂心血管与代谢特征比较:全球网络分析 Comparison of cardiovascular and metabolic profiles in lorlatinib vs. other ALK inhibitors in global network | Szu-Han Wang | 台南医院 |
淋巴瘤含蒽环类化疗后心血管不良事件的发生率与预测因素:回顾性纵向队列 Incidence and predictors of cardiovascular adverse events after anthracycline-containing chemotherapy in lymphoma: a retrospective longitudinal cohort | Dewan Zhao | 大连医科大学附属第一医院 |
急性冠脉综合征后的癌症特异性死亡率:全国真实世界队列的启示 Cancer-specific mortality after acute coronary syndrome: insights from a nationwide real-world cohort | Mingxuan Li | 中国心脏之家 |
新诊断多发性骨髓瘤的心血管不良事件:发生率、预测因素与预后影响 Cardiovascular adverse events in newly diagnosed multiple myeloma: incidence, predictors, and prognostic impact | Dewan Zhao | 大连医科大学附属第一医院 |
乳腺癌患者治疗后心肌损伤列线图预测模型的构建与验证 Construction and validation of a nomogram prediction model for myocardial injury in breast cancer patients after treatment | Yinyin Zhang | 中山大学孙逸仙纪念医院 |
VEGF–TKI所致高血压的独特血压变异表型:肿瘤心脏病学人群间的比较研究 Distinct blood pressure variability phenotype in VEGF–TKI–induced hypertension: a comparative study across cardio-oncology populations | Heng Yu | 兰州大学第二医院 |
Mdivi-1通过改善阿帕替尼诱导的Drp1介导的线粒体过度分裂降低荷胃癌裸鼠血压 Mdivi-1 reduces blood pressure in gastric cancer-bearing nude mice by ameliorating apatinib-induced Drp1-mediated excessive mitochondrial fission | Jing Yu | 兰州大学第二医院 |
C3a–C3aR1介导的心脏成纤维细胞与巨噬细胞交互驱动ICI相关心肌炎进展 C3a–C3aR1–mediated crosstalk between cardiac fibroblasts and macrophages drives the progression of ICI-associated myocarditis | Hongjian Dong | 东南大学附属中大医院 |
健康饮食模式与癌症幸存者新发心血管疾病:前瞻性队列研究 Healthy dietary patterns and incident cardiovascular disease in cancer survivors: a prospective cohort study | Qingyuan Gao | 中山大学孙逸仙纪念医院 |
| 肾功能衰竭与心血管疾病 · 9 篇 | ||
慢性肾脏病合并冠心病患者中复合胰岛素抵抗炎症生物标志物的预后分层:跨血糖状态分析 Prognostic stratification with composite insulin resistance inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses | Zixiang Ye | 国家心血管病中心、阜外医院心血管疾病国家重点实验室 |
术前肾功能、术后急性肾损伤与冠状动脉旁路移植术后5年死亡率:因果中介分析 Preoperative renal function, postoperative acute kidney injury, and 5-year mortality after coronary artery bypass grafting: a causal mediation analysis | Runze Chen | 国家心血管病中心、阜外医院心血管疾病国家重点实验室 |
亚洲大队列中不同KDIGO危险分层的远期心血管结局 Long-term cardiovascular outcomes across KDOKI risk categories in a large Asian cohort | Jui-Tzu Huang | 台北荣民总医院 |
CHA2DS2-VASc评分对伴与不伴既往心肌梗死房颤患者ESRD的不同预测效力 Different prediction power of ESRD by CHA2DS2-VASc score in AF patients with or without prior myocardial infarction | Pang Shuo Huang | 辅仁大学附设医院 |
沙库巴曲缬沙坦在射血分数减低型心力衰竭合并晚期慢性肾脏病中的心肾权衡:倾向加权多中心分析 Cardiorenal trade-off of sacubitril/valsartan in heart failure with reduced ejection fraction and advanced chronic kidney disease: a propensity-weighted multicentre analysis | Chien-Yi Hsu | 台北医科大学附设医院 |
肾功能不全急性心肌梗死患者中营养状态调节的LDL-C预后悖论:多中心回顾性队列研究 The prognostic paradox of LDL cholesterol modulated by nutritional status in acute myocardial infarction patients with renal impairment: a multicenter retrospective cohort study | Hao Zhang | 天津医科大学第二医院 |
心血管-肾脏-代谢重叠对NSTEMI患者预后的影响:多队列研究 Prognostic impact of cardiovascular-kidney-metabolic overlap among patients with non-ST-segment elevation myocardial infarction: a multi-cohort study | Jing Gao | 天津市胸科医院 |
单核细胞/淋巴细胞比值与估计肾小球滤过率对合并慢性肾脏病的AMI患者远期生存的协同影响 Synergistic impact of monocyte-to-lymphocyte ratio and estimated glomerular filtration rate on long-term survival in ami patients with chronic kidney disease | Xiaozhao Lu | 广东省人民医院 |
有创评估的延迟治疗介导了晚期慢性肾脏病NSTEMI患者四分之一的超额死亡:大规模多中心分析 The withholding of invasive assessment mediates one-quarter of excess mortality in NSTEMI patients with advanced chronic kidney disease: a large-scale multicenter analysis | Wenbo Dai | 天津医科大学第二医院 |
| 老年心血管疾病 · 6 篇 | ||
标准化多组分管理对心血管疾病患者医疗服务利用与费用的影响:纵向研究 Impact of standardized multicomponent management on healthcare utilization and costs among patients with cardiovascular disease: a longitudinal study | Weiping Cao | 乐山市人民医院 |
衰弱削弱急性心肌梗死中年龄的预后影响 Frailty attenuates the prognostic impact of age in acute myocardial infarction | Rongxin Guo | 天津医科大学第二医院 |
DNA甲基化(表观遗传)时钟尤其是GrimAge2的加速可预测老年人急性冠脉综合征发病 Acceleration of DNA methylation (epigenetic) clocks especially GrimAge2 can predict incident acute coronary syndrome in older adults | Erik Fung | 香港科技大学 |
衰弱对心血管-肾脏-代谢多病共存时间序列的影响:队列研究 Effect of frailty on the temporal sequence of cardiovascular-kidney-metabolic multimorbidity: a cohort study | Jingkuo Li | 国家心血管病中心、阜外医院心血管疾病国家重点实验室 |
替格瑞洛对比氯吡格雷治疗≥75岁STEMI老年患者的比较效果:目标试验模拟研究 Comparative effectiveness of ticagrelor versus clopidogrel in older adults (≥75 years) with ST-segment elevation myocardial infarction: a target trial emulation study | Rongxin Guo | 天津医科大学第二医院 |
CVMI-age量化多维度心血管衰老并预测心血管事件:中国社区队列研究 CVMI-age quantifies multidimensional cardiovascular aging and predicts cardiovascular events: a Chinese community-based cohort study | Haotai Xie | 北京大学第一医院 |
| 自身免疫性与慢性炎症性疾病 · 5 篇 | ||
冠心病合并类风湿关节炎患者的性别悖论:全国性队列研究 The "sex paradox" in patients with coexistent coronary heart disease and rheumatoid arthritis: a nationwide cohort study | Wenjie Chen | 首都医科大学附属北京朝阳医院 |
STEMI患者TET2-意义未明克隆性造血突变与hs-CRP的双向孟德尔随机化研究 Bidirectional mendelian randomzation study of TET2-clonal haematopoiesis of indeterminate potential-mutations with hs-CRP in patients with STEMI | Xiaoxiao Zhao | 国家心血管病中心、阜外医院心血管疾病国家重点实验室 |
血管老化是脂肪性肝病肝纤维化的早期驱动因素:揭示代谢依赖的治疗机会窗口 Vascular aging as an early driver of hepatic fibrosis in steatotic liver disease: unveiling a metabolic-dependent window of opportunity | Wei-Ting Wang | 台北荣民总医院 |
高同型半胱氨酸血症通过B细胞来源的抗β2糖蛋白I介导的内皮损伤加速动脉粥样硬化 Hyperhomocysteinemia accelerates atherosclerosis through a B cell–derived anti-β2 glycoprotein I–mediated endothelial injury | Hongyu Chen | 北京大学第一医院 |
基于血清标志物推断CD4+T细胞谱系转变的框架:动脉粥样硬化中的TPI模型 A serum-marker-based framework for inferring CD4+T-cell lineage shifts: introducing the tpi model in atherosclerosis | Caixia Lu | 河北省人民医院 |
| 女性心血管疾病 · 3 篇 | ||
肝功能不全急性心肌梗死患者的性别特异性LDL-C目标区间:真实世界队列分析 Gender-specific LDL-c target windows in acute myocardial infarction patients with liver dysfunction: a real-world cohort analysis | Rongxin Guo | 天津医科大学第二医院 |
心血管随机对照试验中性别代表性失衡对效应量的影响 Impact of sex-representation imbalance on effect sizes in cardiovascular randomized controlled trials | Xiaoying Zhong | 北京中医药大学东直门医院 |
重新审视转甲状腺素蛋白心肌病的室壁厚度:SMART国际队列中的性别差异 Rethinking wall thickness in transthyretin amyloid cardiomyopathy: sex-specific difference in the multinational SMART cohort | Yi-Hsin Hung | 台湾大学癌医中心 |
| 妊娠与心血管疾病 · 3 篇 | ||
孕前肥胖、不良妊娠结局模式与产后早期心脏代谢风险:潜类别分析识别的中介分析 Prepregnancy obesity, adverse pregnancy outcome patterns, and early postpartum cardiometabolic risk: a mediation analysis identified by latent class analysis | Jingge Li | 天津医科大学总医院 |
孕16周前使用阿司匹林与产后早期心脏代谢风险的关联:基于电子病历的研究 Association between aspirin use before 16 weeks of gestation and early postpartum cardiometabolic risk: an electronic health record–based study | Jingge Li | 天津医科大学总医院 |
母亲睡眠障碍通过中性粒细胞免疫代谢重编程驱动子痫前期 Maternal sleep disorders drive preeclampsia via immunometabolic reprogramming of neutrophils | Jie Zhu | 复旦大学 |
04企业卫星会Industry Symposia5 个系列
赞助商分布9 场 · AstraZeneca 8 场 · Boehringer Ingelheim 4 场 · Philips 2 场 · Siemens Healthineers 1 场 · Radcliffe
慢性肾病与心肾1 个系列
Radcliffe
心肾风险管理:基层医疗与心脏科的衔接
Cardiorenal risk management at the interface of primary care and cardiology
欢迎、介绍与课前测试
Welcome, introduction and pre-test
心肾保护的基础:指南怎么说
The foundation of cardiorenal protection: what the guidelines say
基于 SGLT2 抑制剂的策略优化管理
Optimising management with SGLT-2i-based strategies
听众问答:明天即可用于临床的实用方案
Audience Q&A: practical solutions for your practice tomorrow
要点回顾、课后测验与闭幕致辞
Key takeaways, post-test and closing remarks
AI 与数字技术1 个系列
AstraZeneca
用人工智能重新定义遗传型 ATTR(ATTRv)的早期诊断(系列共 9 场)
Redefining early diagnosis of hereditary transthyretin amyloidosis (ATTRv) with artificial intelligence
用人工智能重新定义遗传性转甲状腺素蛋白淀粉样变性(ATTRv)的早期诊断
Redefining early diagnosis of hereditary transthyretin amyloidosis (ATTRv) with artificial intelligence
肿瘤心脏病学1 个系列
Siemens Healthineers
人工智能驱动心脏肿瘤学变革:从预测到预防(系列共 2 场)
Artificial intelligence powered transformation of cardio-oncology: from prediction to prevention
AI 驱动的肿瘤心脏病学变革:从预测到预防
Artificial intelligence powered transformation of cardio-oncology: from prediction to prevention
综合与其他2 个系列
Boehringer Ingelheim
基层心血管风险管理:面向基层医生的实践教程(系列共 8 场)
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorials for primary care physicians and professionals
基层医疗中的心血管风险管理:患者的突破——面向基层医生与专业人士的教程
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorialsl for primary care physicians and professionals
基层医疗中的心血管风险管理:患者的突破——面向基层医生与专业人士的教程
Cardiovascular risk management in primary care: a breakthrough for patients - Tutorials for primary care physicians and professionals
Philips
十分钟超快心脏磁共振应变评估:心脏毒性的诊断与管理(系列共 4 场)
10-min ultrafast CMR-based strain assessment for cardio-toxicity diagnosis and management
10 分钟超快速 CMR 应变评估用于心脏毒性诊断与管理
10-min ultrafast CMR-based strain assessment for cardio-toxicity diagnosis and management
企业卫星会内容由赞助方支持,此处仅作学术日程信息陈列,不代表编辑立场。